Locations:

GI

22-DDI-3242262 – Neuroendocrine Tumor-Kim-3-hero

December 15, 2022/Cancer

Neuroendocrine Tumors: Today’s GIs Likely Will Encounter Them

Cleveland Clinic program to streamline clinical care and research

June 4, 2021/Digestive/GI

Biosimilar Safety and Efficacy Comparable to Biologic Treatment in IBD Patients

Infliximab-abda offers similar benefits at lower costs

21-DDI-2066394-CCJM-Curbside-GI-Manifestations

March 1, 2021/COVID-19

Gastrointestinal Manifestations of COVID-19

Prevalence, characteristics and disease course

20-DDI-1983916-ACG-Decreasing-Colectomy-UC-Biologic-Medications

October 26, 2020/Digestive/GI

20 Years of Colectomy and Biologics for Ulcerative Colitis

How rates of colectomy and biologics use have changed over time

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

20-DDI-1971030-Sulindac-and-Eflornithine-Combination-Delays

October 26, 2020/Digestive/GI

Combination Therapy Delays Need for Lower GI Surgery in Patients with Familial Adenomatous Polyposis

Post hoc analysis of phase 3 trial shows benefit

17-CCC-3817-GettyImages-543353618-650×450

September 23, 2020/Digestive/GI

Entrustable Professional Activities Established for Advanced IBD Fellowships

On the purpose, process and results

September 22, 2016/Cancer

Managing Lynch and FAP: A Balance Between Cancer Prevention and Quality of Life

Action items for managing these complex patients

BackPage 1 of 1Next